Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Invested Capital (2016 - 2021)

Phio Pharmaceuticals' Invested Capital history spans 10 years, with the latest figure at $25.2 million for Q3 2021.

  • For Q3 2021, Invested Capital rose 63.37% year-over-year to $25.2 million; the TTM value through Sep 2021 reached $25.2 million, up 63.37%, while the annual FY2020 figure was $13.0 million, 126.46% up from the prior year.
  • Invested Capital reached $25.2 million in Q3 2021 per PHIO's latest filing, down from $28.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $31.4 million in Q1 2021 to a low of $567000.0 in Q1 2018.
  • Average Invested Capital over 5 years is $11.4 million, with a median of $9.7 million recorded in 2019.
  • Peak YoY movement for Invested Capital: crashed 93.12% in 2018, then skyrocketed 1956.79% in 2019.
  • A 5-year view of Invested Capital shows it stood at $1.8 million in 2017, then surged by 640.75% to $13.6 million in 2018, then plummeted by 57.67% to $5.7 million in 2019, then surged by 126.46% to $13.0 million in 2020, then skyrocketed by 93.95% to $25.2 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Invested Capital are $25.2 million (Q3 2021), $28.8 million (Q2 2021), and $31.4 million (Q1 2021).